Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borde

Showing results (671-680 of 700) with videos related to

Pageof 70
Sort By:
Research Square|July 9, 2024
Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liverJose F Delgado, Joshua W Owen, William F Pritchard, et al.
Journal of Cell Science|March 11, 2014
14-3-3γ-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivoLalit Sehgal, Amitabha Mukhopadhyay, Anandi Rajan, et al.
Kidney International|July 23, 2022
COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine respondersHannah Kaminski, Mickael Gigan, Agathe Vermorel, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 21, 2020
Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor MicroenvironmentTabea Borde, Fabian Laage Gaupp, Jean-Francois Geschwind, et al.
European Radiology|October 31, 2021
Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor modelLuzie A Doemel, Jessica G Santana, Lynn J Savic, et al.
Clinical Case Reports|May 19, 2023
Hairy cell leukemia with isolated bone lesionsLaura Cailly, Cécile Gruchet, Elsa Maitre, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR InhibitorsGilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
Nature Immunology|February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.
BMC Cancer|June 27, 2022
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriersJulika Borde, Yael Laitman, Britta Blümcke, et al.
Pageof 70

Showing results (671-680 of 700) with videos related to

Sort By:
Pageof 70
Research Square|July 9, 2024
Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liverJose F Delgado, Joshua W Owen, William F Pritchard, et al.
Journal of Cell Science|March 11, 2014
14-3-3γ-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivoLalit Sehgal, Amitabha Mukhopadhyay, Anandi Rajan, et al.
Kidney International|July 23, 2022
COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine respondersHannah Kaminski, Mickael Gigan, Agathe Vermorel, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 21, 2020
Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor MicroenvironmentTabea Borde, Fabian Laage Gaupp, Jean-Francois Geschwind, et al.
European Radiology|October 31, 2021
Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor modelLuzie A Doemel, Jessica G Santana, Lynn J Savic, et al.
Clinical Case Reports|May 19, 2023
Hairy cell leukemia with isolated bone lesionsLaura Cailly, Cécile Gruchet, Elsa Maitre, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR InhibitorsGilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
Nature Immunology|February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.
BMC Cancer|June 27, 2022
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriersJulika Borde, Yael Laitman, Britta Blümcke, et al.
Pageof 70